
Gilde Healthcare closes third fund on €200m
Gilde Healthcare has held a first and final close for its third private equity fund, Gilde Healthcare Services III, on its €200m hard-cap.
The vehicle focuses on lower-mid-market healthcare providers and suppliers of medical products, and is managed by Gilde's investment teams based in its Utrecht and Frankfurt offices.
The fund is double the size of its predecessor, Gilde Healthcare Services II, which closed in January 2015 on €100m.
Investors
The fund's LP base is mainly composed of Dutch institutional investors, including healthcare workers pension fund PGGM/Pensioenfonds Zorg en Welzijn, and bank and financial services provider Rabo Corporate Investments, as well as several international funds-of-funds.
Investments
The fund targets companies based in the Benelux and DACH regions that generate EBITDA of between €2-15m and revenues in the €10-30m range. Targets must operate in the healthcare industry and related sectors, including long-term care providers and clinics, suppliers of medical products, and laboratories.
Gilde Healthcare Services III deploys equity tickets in the €10-40m bracket and is open to co-investments for larger transactions. The fund will use moderate leverage of around 3x, increasing or reducing the debt financing according to the growth plan of the target company.
People
Gilde Healthcare – Jasper van Gorp (managing partner).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater